Literature DB >> 12840118

Emergency management of atrial fibrillation.

A Wakai1, J O O'Neill.   

Abstract

Atrial fibrillation is the most common cardiac arrhythmia managed by emergency and acute general physicians. There is increasing evidence that selected patients with acute atrial fibrillation can be safely managed in the emergency department without the need for hospital admission. Meanwhile, there is significant variation in the current emergency management of acute atrial fibrillation. This review discusses evidence based emergency management of atrial fibrillation. The principles of emergency management of acute atrial fibrillation and the subset of patients who may not need hospital admission are reviewed. Finally, the need for evidence based guidelines before emergency department based clinical pathways for the management of acute atrial fibrillation becomes routine clinical practice is highlighted.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12840118      PMCID: PMC1742715          DOI: 10.1136/pmj.79.932.313

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  54 in total

1.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Authors:  Isabelle C Van Gelder; Vincent E Hagens; Hans A Bosker; J Herre Kingma; Otto Kamp; Tsjerk Kingma; Salah A Said; Julius I Darmanata; Alphons J M Timmermans; Jan G P Tijssen; Harry J G M Crijns
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

2.  Safety and efficacy of in-office cardioversion for treatment of supraventricular arrhythmias.

Authors:  M F Lesser
Journal:  Am J Cardiol       Date:  1990-11-15       Impact factor: 2.778

Review 3.  Management of atrial fibrillation.

Authors:  E L Pritchett
Journal:  N Engl J Med       Date:  1992-05-07       Impact factor: 91.245

4.  Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter.

Authors:  A T Gosselink; H J Crijns; I C Van Gelder; H Hillige; A C Wiesfeld; K I Lie
Journal:  JAMA       Date:  1992-06-24       Impact factor: 56.272

5.  Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation.

Authors:  W J Manning; D I Silverman; S E Katz; M F Riley; P C Come; R M Doherty; J T Munson; P S Douglas
Journal:  J Am Coll Cardiol       Date:  1994-06       Impact factor: 24.094

6.  Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation.

Authors:  S Juul-Möller; N Edvardsson; N Rehnqvist-Ahlberg
Journal:  Circulation       Date:  1990-12       Impact factor: 29.690

7.  Lone atrial fibrillation in elderly persons: a marker for cardiovascular risk.

Authors:  S L Kopecky; B J Gersh; M D McGoon; C P Chu; D M Ilstrup; J H Chesebro; J P Whisnant
Journal:  Arch Intern Med       Date:  1999-05-24

Review 8.  Digoxin for atrial fibrillation: a drug whose time has gone?

Authors:  R H Falk; J I Leavitt
Journal:  Ann Intern Med       Date:  1991-04-01       Impact factor: 25.391

9.  Time of occurrence, duration, and ventricular rate of paroxysmal atrial fibrillation: the effect of digoxin.

Authors:  J M Rawles; M J Metcalfe; K Jennings
Journal:  Br Heart J       Date:  1990-04

10.  Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.

Authors:  E J Benjamin; D Levy; S M Vaziri; R B D'Agostino; A J Belanger; P A Wolf
Journal:  JAMA       Date:  1994-03-16       Impact factor: 56.272

View more
  5 in total

1.  Population pharmacokinetic-pharmacodynamic analysis of vernakalant hydrochloride injection (RSD1235) in atrial fibrillation or atrial flutter.

Authors:  Zhongping Mao; Jeff J Wheeler; Robert Townsend; Yuying Gao; Smita Kshirsagar; James J Keirns
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-07-24       Impact factor: 2.745

2.  Evaluation of transient ischemic attack in an emergency department observation unit.

Authors:  Latha G Stead; M Fernanda Bellolio; Smitha Suravaram; Robert D Brown; Anjali Bhagra; Rachel M Gilmore; Eric T Boie; Wyatt W Decker
Journal:  Neurocrit Care       Date:  2008-10-11       Impact factor: 3.210

3.  Vernakalant versus ibutilide for immediate conversion of recent-onset atrial fibrillation.

Authors:  I Vogiatzis; E Papavasiliou; I Dapcevitch; S Pittas; E Koulouris
Journal:  Hippokratia       Date:  2017 Apr-Jun       Impact factor: 0.471

4.  Efficacy and safety in pharmacological cardioversion of recent-onset atrial fibrillation: a propensity score matching to compare amiodarone vs class IC antiarrhythmic drugs.

Authors:  Antonio Bonora; Gianni Turcato; Elena Franchi; Gabriele Taioli; Alice Dilda; Germana Zerman; Antonio Maccagnani; Claudio Pistorelli; Oliviero Olivieri
Journal:  Intern Emerg Med       Date:  2016-07-06       Impact factor: 3.397

Review 5.  An Integrative Comparative Study Between Digoxin and Amiodarone as an Emergency Treatment for Patients With Atrial Fibrillation With Evidence of Heart Failure: A Systematic Review and Meta-Analysis.

Authors:  Hany A Zaki; Khalid Bashir; Haris Iftikhar; Waleed Salem; Eslam Hussein Mohamed; Helmy M Elhag; Mohamed Hendy; Ahmed Abdu O Kassem; Emad El-Din Salem; Amr Elmoheen
Journal:  Cureus       Date:  2022-07-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.